Related Experiment Video
Updated: Jul 14, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Compliance with Low Molecular Weight Heparin in abulatory orthopedic patients
Michał Karliński1, Artur Stolarczyk, Marcin Siuda
1(1) Klinika Ortopedii i Rehabilitacji, Akademia Medyczna w Warszawie.
Abstract:
Background The prophylaxis of venous thromboembolism with unfractioned heparins (UFH) was introduced in 1970s and initially applied only in high-risk orthopedic surgery patients. While further studies proved its importance also in those with lower risk, it was the development of LMWH, that enabled wide practical application. The primary objective of this study was to provide a complex evaluation of actual compliance with self-administered Low Molecular Weight Heparin in ambulatory orthopedic patients. Assessment of incidence of LMWH side-effects and thromboembolic episodes despite proper prophylaxis were defined as secondary objectives. Material and methods The research was conducted in Brodnowski Hospital, Warsaw and WSzZ Hospital, Kielce. The group consisted of n=120 (58 females, age 17-82) patients. The selection criteria were: having plaster immobilization definitely removed and being prescribed LMWH as a part of the treatment. Participants were given anonymous questionnaires composed of 25 questions. Satisfactory compliance was defined as application of at least 80% of prescribed injections. Results Compliance with LMWH appeared to be satisfactory in 95.8% cases of which 63,6% were fully and 32,2% partially compliant. The most frequent reasons for dose omission were forgetfulness (48.9%), fear of side-effects (20.0%) and side-effects (13.3%). Side effects were observed in 26.7% of drug applying patients and due to this fact 16.4% temporarily stopped injections. Venous thromboembolism was reported in 6.0%. Conclusions Compliance level in great majority proved to be satisfactory, although the necessity of prophylaxis was far from being fully recognized by the patients. It also seemed unaffected by the significant number of side effects. Thromboembolic episodes were sporadically reported.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization IV: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...